Okano, N., Furuse, J., Ueno, M., Morizane, C., Yamanaka, T., Ojima, H., . . . Okusaka, T. (2020). Multicenter Phase II Trial of Axitinib Monotherapy for Gemcitabine‐Based Chemotherapy Refractory Advanced Biliary Tract Cancer (AX‐BC Study). Oncologist.
Chicago-стиль цитированияOkano, Naohiro, et al. "Multicenter Phase II Trial of Axitinib Monotherapy for Gemcitabine‐Based Chemotherapy Refractory Advanced Biliary Tract Cancer (AX‐BC Study)." Oncologist 2020.
MLA-цитированиеOkano, Naohiro, et al. "Multicenter Phase II Trial of Axitinib Monotherapy for Gemcitabine‐Based Chemotherapy Refractory Advanced Biliary Tract Cancer (AX‐BC Study)." Oncologist 2020.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.